Clinical Trials Browser

Nasopharyngeal Carcinoma

NCT05389306 2026-03-03

NPC-LN

Phase NA Completed

348 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Disease

NCT01365169 2026-01-07

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Phase NA Recruiting

590 enrolled

GastrointestinalHead & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Neoplasm Metastasis, Neoplasms, Oropharyngeal Neoplasms, Somatostatinoma, Colorectal Neoplasms

NCT07248696 2025-11-25

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Phase NA Active not recruiting

32 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT07019870 2025-06-13

Screening for Early Diagnosis of Nose Cancer

Phase NA Recruiting

20,000 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT04823468 2025-06-10

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Phase NA Completed

236 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Body Weight

NCT05741008 2025-04-27

Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

Phase NA Completed

20 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT06682442 2025-04-20

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Phase NA Recruiting

66 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections

NCT06662058 2025-04-10

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

Phase NA Recruiting

118 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Clinical Trials

Proton Therapy for Recurrent Nasopharyngeal Carcinoma

NPC-LN

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II Trial

Screening for Early Diagnosis of Nose Cancer

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma

Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation